Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Cancer Research and Treatment
>
2004
>
36
>
6
Volume:
36
Issue:
6
1. HIF-1alpha: a Valid Therapeutic Target for Tumor Therapy.
Page:343—353
2. Preoperative Concurrent Chemoradiotherapy with Oral Fluoropyrimidine in Locally Advanced Rectal Cancer: How Good Is Good Enough?.
Page:341—342
3. Proteome Analysis of Differential Protein Expression in Cervical Cancer Cells after Paclitaxel Treatment.
Page:395—399
4. Photodynamic Effects of Radachlorin(R) on Cervical Cancer Cells.
Page:389—394
5. Expression of Matrix Metalloproteinase-9 Correlates with Poor Prognosis in Human Malignant Fibrous Histiocytoma.
Page:384—388
6. An Analysis of the Risk Factors and Management of Lymphocele after Pelvic Lymphadenectomy in Patients with Gynecologic Malignancies.
Page:377—383
7. Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients.
Page:372—376
8. The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-Fluorouracil Based Chemotherapy.
Page:367—371
9. Responsiveness of CPT-11 in Respect to hMLH1 and hMSH2 Protein Expression in the Primary Colorectal Cancer.
Page:360—366
10. Prospective Phase II Study of Preoperative Chemoradiation with Capecitabine in Locally Advanced Rectal Cancer.
Page:354—359